0001640455-22-000035.txt : 20220317 0001640455-22-000035.hdr.sgml : 20220317 20220317205055 ACCESSION NUMBER: 0001640455-22-000035 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cole Hugh M CENTRAL INDEX KEY: 0001604646 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 22750799 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 wf-form4a_164756463871771.xml FORM 4/A X0306 4/A 2022-02-01 2022-02-03 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001604646 Cole Hugh M C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Business Officer Stock Option (Right to Buy) 7.56 2022-02-01 4 A 0 85000 0 A 2032-02-01 Common Stock 85000.0 85000 D The Stock Option will vest (i) as to 55,000 shares of the Stock Option, quarterly in 16 equal installments following January 1, 2022 and (ii) as to 30,000 shares of the Stock Option, on January 1, 2023. This Form 4/A amends the Form 4 filed on February 3, 2022 to correct the vesting schedule of the Stock Option granted to the Reporting Person. /s/ Caroline Gammill, Attorney-in-fact 2022-03-17